"Designing Growth Strategies is in our DNA"

Injectable Nanomedicine Market Size, Share & Industry Analysis, By Drug Type (Liposomes, Nanocrystals, Micelles, Polymeric Nanoparticles, Others), By Application (Cancer, Cardiovascular Diseases, Central Nervous System Diseases, Infection Control, Inflammatory Diseases, Others), By End User (Hospitals, Clinics, R&D Institutes, Others) And Regional Forecast, 2024-2032

Region :Global | Report ID: FBI105838 | Status : Ongoing



Nanotechnology has been the subject of extensive studies in the application of various drug delivery systems for various routes of administration. Nanomedicine combines nanotchnology with pharmaceutical and biomedical science to develop drugs with several advantages like targeted drug delivery, reduced toxicity, long circulation, and enhanced half-life.

Rising incidence of chronic diseases like cancer, cardiovascular diseases, etc, coupled with the growing demand for injectabel nanomedicine, and increasing government as well as private funding for the development of nanomedicine are some of the factors that is anticpated to drive the injectable nanomedicines market during the forecast period. According to American Health Association, it is expected that about 60% i.e. 170 million Americans will be suffering from some form of chronic disesases by 2030.

The injectable nanomedicine market is expected to register a significant growth during the forecast period due to factors such as rising number of cases of chronic disorders, rising research and development activities for the launch of injectable nanomedicine, and increasing number of collaboration between academic and pharmaceutical industries for the new product introductions. However, low approval rate for clinical use due to disadvantages such as drug deposition and thereby organ or site toxicity is the major factor anticipated to restrict the growth of injectable nanomedicine market.

Key Market Driver -

Rising incidence of Chronic Diseases, Increasing government and private funding for development of nanomedicines.

Key Market Restraint -

Stringent regulatory framework, difficulty in nanoscale manufacturing

Market Segmentation:

Globally, the injectable nanomedicine market can be segmented on the basis of the drug delivery type, application, end user and region. Based on the type of drug delivery, the market can be segmented into liposomes, nanocrystals, micelles, polymeric nanoparticles, mesoporous silica nanoparticles, metallic nanoparticles, and others. Based on applications, the market can be further segmented into cancer, cardiovascular diseases, central nervous system diseases, infection control, inflammatory diseases, and others. Based on end user, the market can be segmented into hospitals, ambulatory surgical centres, clinics, R&D institutes, managed care organization, and others. Geographically, the injectable nanomedicine market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

Key Players Covered:

Some of the major companies that are present in the injectable nanomedicine market are Lupin, , Pacira BioSciences, Inc., BioDelivery Sciences International, Inc., Amgen Inc., CELGENE CORPORATION, Teva Pharmaceutical Industries Ltd, Pfizer Inc, Hoffmann-La Roche Ltd, and other prominent players.

Key Insights:

  • Key Industry Trends

  • Prevalence of Chronic Diseases, By Key Countries/Key Regions

  • New Product Launches

  • Key Industry Developments Mergers, Acquisitions, And Collaborations

Regional Analysis:

Geographically, the injectable nanomedicine market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to account for maximum share of the injectable nanomedicine market. The dominance is attributable to the increasing research collaborations between pharmaceutical and academia, and growing prevalence pf chronic diseases, and availability of progressive healthcare facilities. For instance, in February 2021, an interdisciplinary research team at Northern Arizona University is working with partners throughout the U.S. on nanotechnology to streamline vaccine delivery.

Europe is anticipated to hold second largest market share in global market. Availability of sterile GMP approved sites for the development and manufacturing of nanomedicine is projected to fuel the market growth in this region. Moreover, the improved healthcare infrastructure coupled with the higher penetration of the key player in the region is anticipated to augment the market growth during the forecast period. On the other hand, Asia Pacific is expected to register the highest CAGR. Increasing healthcare investment in the developing countries of the region and rising aging population coupled with the growing prevalence of various infectious and chronic diseases propel the market growth of this region. For instance, about 75 million people in India above 60 years of age suffer from some chronic disease.

Latin America and Middle East Africa are anticipated to witness a moderate growth during the forecast period due to less awareness among the population regarding the advanced healthcare technologies and developing healthcare infrastructure in these regions.

To gain extensive insights into the market, Request for Customization




By Drug Type

  • Liposomes

  • Nanocrystals

  • Micelles

  • Polymeric Nanoparticles

  • Others

By Application

  • Cancer

  • Cardiovascular Diseases

  • Central Nervous System Diseases

  • Infection Control

  • Inflammatory Diseases

  • Others

By End User

  • Hospitals

  • Clinics

  • R&D Institutes

  • Others

By Geography

  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, and Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Injectable Nanomedicine Market Industry Developments

  • In March 2021, PACIRA Biosciences, Inc. got FDA approval for EXPAREL (BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION) which is a new drug application in pediatric patients.

  • In March 2021, Jazz Pharmaceutical announced additional for Vyxeos (Daunorubicin and Cytarabine) For The Treatment of Secondary Acute Myeloid Leukemia.

  • Ongoing
  • 2023
  • 2019-2022

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Siemens Healthineers

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.